Report
EUR 236.14 For Business Accounts Only

Stagnating top-line

Julphar reported FY 2016 slight revenue decline of 1.1% to AED1.454bn vs. AED1.47bn a year earlier. The net operating profit decreased by 8.9% to AED229.23m, down from AED249.68m in 2015. The net income for the period was down by 7.3% to AED210.03m vs. AED226.65m a year earlier. Thus, the net margin rate lost 100 basis points to establish at 14.4%.
Underlying
Gulf Pharmaceutical Industries

Provider
AlphaMena Corporate Services
AlphaMena Corporate Services

AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.

Analysts
Ghada JENDOUBI

Other Reports on these Companies
Other Reports from AlphaMena Corporate Services

ResearchPool Subscriptions

Get the most out of your insights

Get in touch